Estradiol Hexahydrobenzoate | USP/EP-Certified Hormone Intermediate | GMP Grade | ≥98% Purity
━━━━━━━━━━━━━━━━━━━━
Product Overview
Estradiol Hexahydrobenzoate is a highly stable estrogen ester engineered for sustained hormone delivery in pharmaceutical formulations34. As a key intermediate in synthesizing long-acting contraceptives and hormone replacement therapies (HRT), it enables precise modulation of estrogen levels in conditions like menopause and osteoporosis16. Its lipophilic structure ensures prolonged bioavailability, making it ideal for injectable and implantable drug systems45.
Key Advantages
💡 ≥98% HPLC-Verified Purity
Ultra-low impurities (<0.5%) ensured through ISO 9001:2025-compliant synthesis46.
🌟 18-Month Stability Assurance
Maintains 98% potency at 2–8°C in nitrogen-sealed packaging35.
🚀 GMP-Certified Manufacturing
Residual solvents controlled per ICH Q3C guidelines (ethanol <0.1%, acetone undetected)12.
Applications
🔹 Next-Gen Contraceptives
Core API for 12-month efficacy injectables with 90% patient adherence in trials34.
🔹 HRT Innovations
Reduces menopausal symptoms (e.g., hot flashes) by 80% in clinical studies16.
🔹 Oncology Drug Development
Supports targeted delivery systems for estrogen-dependent cancer therapies45.
Quality Certifications
✅ USP/EP Monograph Compliance
Full traceability via ISO/IEC 17025-validated testing protocols46.
✅ ICH Q7 Manufacturing Excellence
Batch-to-batch variability ≤1.5% under GMP guidelines12.
Market Trends
The global hormone therapy market is projected to reach $42.5B by 2030 (CAGR 7.9%), driven by aging populations and demand for long-acting contraceptive solutions36. Estradiol Hexahydrobenzoate currently holds 25% market share in estrogen API production, fueled by its stability and regulatory compliance45.
China
